SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-034773
Filing Date
2023-07-26
Accepted
2023-07-26 16:46:18
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-20230630.htm   iXBRL 10-Q 3014108
2 EX-10.1 vktx-ex10_1.htm EX-10.1 143297
3 EX-31.1 vktx-ex31_1.htm EX-31.1 21154
4 EX-31.2 vktx-ex31_2.htm EX-31.2 21132
5 EX-32.1 vktx-ex32_1.htm EX-32.1 16717
  Complete submission text file 0000950170-23-034773.txt   10237171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vktx-20230630_lab.xml EX-101.LAB 416672
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vktx-20230630.xsd EX-101.SCH 48244
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vktx-20230630_cal.xml EX-101.CAL 43147
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vktx-20230630_pre.xml EX-101.PRE 314685
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vktx-20230630_def.xml EX-101.DEF 172579
52 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20230630_htm.xml XML 2015435
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 231114177
SIC: 2834 Pharmaceutical Preparations